Literature DB >> 26515620

Progressive Muscular Atrophy.

Teerin Liewluck1, David S Saperstein2.   

Abstract

Progressive muscular atrophy (PMA) is a rare, sporadic, adult-onset motor neuron disease, clinically characterized by isolated lower motor neuron features; however, clinically evident upper motor neuron signs may emerge in some patients. Subclinical upper motor neuron involvement is identified pathologically, radiologically, and neurophysiologically in a substantial number of patients with PMA. Patients with subclinical upper motor neuron involvement do not fulfill the revised El Escorial criteria to participate in amyotrophic lateral sclerosis clinical trials. Intravenous immunoglobulin therapy is only marginally beneficial in a small subgroup of patients with lower motor neuron syndrome without conduction block.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lower motor neuron syndrome; Lower motor neuron-onset ALS; PMA; Progressive muscular atrophy

Mesh:

Substances:

Year:  2015        PMID: 26515620     DOI: 10.1016/j.ncl.2015.07.005

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  12 in total

1.  Clinical Utility of Repetitive Nerve Stimulation Test in Differentiating Multifocal Motor Neuropathy From Progressive Muscular Atrophy.

Authors:  Shunsuke Watanabe; Kenji Sekiguchi; Yoshikatsu Noda; Riki Matsumoto
Journal:  J Clin Neuromuscul Dis       Date:  2022-06-01

2.  [Calculation of the prevalence of progressive muscular atrophy among adults in China based on urban medical insurance data from 15 provinces].

Authors:  L Xu; L Chen; D S Fan; J N Feng; L L Liu; S Y Zhan; S F Wang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-06-18

3.  Generation and optimization of highly pure motor neurons from human induced pluripotent stem cells via lentiviral delivery of transcription factors.

Authors:  Masood Sepehrimanesh; Baojin Ding
Journal:  Am J Physiol Cell Physiol       Date:  2020-08-12       Impact factor: 4.249

4.  Use of sugammadex in a patient with progressive muscular atrophy and in a patient with amyotrophic lateral sclerosis: Case report.

Authors:  Jae Hwa Yoo; Soon Im Kim; Sun Young Park; Mi Roung Jun; Yong Eun Kim; Hyoung June Kim
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

5.  SMN1 Duplications Are Associated With Progressive Muscular Atrophy, but Not With Multifocal Motor Neuropathy and Primary Lateral Sclerosis.

Authors:  Jeroen W Bos; Ewout J N Groen; Renske I Wadman; Chantall A D Curial; Naomi N Molleman; Marinka Zegers; Paul W J van Vught; Reinier Snetselaar; Raymon Vijzelaar; W Ludo van der Pol; Leonard H van den Berg
Journal:  Neurol Genet       Date:  2021-06-22

Review 6.  Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases.

Authors:  Matthew E R Butchbach
Journal:  Front Mol Biosci       Date:  2016-03-10

7.  A blended psychosocial support program for partners of patients with amyotrophic lateral sclerosis and progressive muscular atrophy: protocol of a randomized controlled trial.

Authors:  Jessica de Wit; Anita Beelen; Constance H C Drossaert; Ruud Kolijn; Leonard H van den Berg; Johanna M A Visser-Meily; Carin D Schröder
Journal:  BMC Psychol       Date:  2018-05-02

8.  Patient characteristics and hospitalisation costs of spinal muscular atrophy in Spain: a retrospective multicentre database analysis.

Authors:  Josep Darbà; Alicia Marsà
Journal:  BMJ Open       Date:  2019-11-21       Impact factor: 2.692

9.  Using Patient-Reported Outcome Measurement Information System Computer Adaptive Testing Domains to Investigate the Impact of Obesity on Physical Function, Pain Interference, and Mental Health in Sports Medicine Patients.

Authors:  Jacob W Blanchett; Noah A Kuhlmann; Mohsin S Fidai; Peter A Borowsky; Stephanie J Muh; Eric C Makhni
Journal:  J Obes Metab Syndr       Date:  2019-12-30

10.  Dissociated leg muscle atrophy in amyotrophic lateral sclerosis/motor neuron disease: the 'split-leg' sign.

Authors:  Young Gi Min; Seok-Jin Choi; Yoon-Ho Hong; Sung-Min Kim; Je-Young Shin; Jung-Joon Sung
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.